Marc DiNardo

Jersey City Police Officer Marc DiNardo, the most seriously injured of the five cops shot Thursday during a shootout on Reed Street, remains hospitalized in critical condition this morning, according to JCPD spokesman Lt. Edgar Martinez. Rumors that he had succumbed to his injuries last night are false, Martinez said.

A 10-year veteran of the Jersey City police force assigned to the Emergency Services Unit, the 37-year-old DiNardo was shot in the face and had to be resuscitated several times that morning, officials said. The condition of the other officer still hospitalized, 25-year-old Michael Camacho, was upgraded from critical but stable condition to "serious but guarded," Martinez said yesterday.

In all, four Jersey City police officers and a Port Authority police officer were shot and two suspects killed during an investigation into the case of a man shot on Broadway last month that had been caught on surveillance video. On Friday, law enforcement officials said the suspects -- 32-year-old Hassain Hosendove and his wife, 22-year-old Amanda Anderson -- may have been responsible for a string of armed robberies from South Carolina to New Jersey.

Stephanie Abrams

Roker and cohost Stephanie Abrams launched their weather-and-headlines program on July 20, with special guest Buzz Aldrin (pictured, with Roker), who celebrated the 40th anniversary of his Apollo 11 lunar landing by correcting Al when he said that Buzz had once described the moon as "magnificent isolation" instead of "magnificent desolation."

Did anyone catch Wake Up with Al? What did you think? My thoughts on the first four minutes: That touch-screen technology might be fun for Al to play with, but its introduction failed to wow me as a home viewer; they need to steal a bigger screen from the set of the NCIS spinoff.

The nickname Al and Stephanie have decided we'll all call their show because it signifies how offbeat they are. WUWA is surprisingly difficult for me to say, so perhaps I'm biased. I do, however, approve of the Wake Up With Al alarm clark giveaway.

Benlysta

Benlysta is an experimental lupus (Any of several forms of ulcerative skin disease) drug which produced positive consequences in a company-backed study has encouraged its makers on Monday to advertize the Benysta drug as potentially the 1st latest drug for lupus in semi century.

The Benlysta drug acts similar to a sort of biological volume control, dialing down the strength of the protected response which attacks lupus patients' tissues, habitually wreaking chaos in essential organs. All 865 patients under examination were given normal treatment for lupus along with steroids as a mainstay of treatment.

Company officials said that more Benlysta patients were capable to decrease their steroid dose and with it also the bloating and other side effects of steroid use. David Stump from “Human Genome Science Inc.” (Which developed the Benlysta drug with “GlaxoSmithKline”) said that it is exceptional news that all investigators they have shown (results) are just delighted. They have not had a first-class clinical trials result in years. Now patients of Lupus should have some hope, too.